Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Hair restoration surgeons must understand the differences between CTE and FPHL for accurate diagnosis and treatment.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

FFA's causes may include environmental triggers and genetic factors.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

Dermoscopes help tell FPHL apart from other hair loss types and can detect it early by identifying specific patterns.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

FFA and FAPD might be related or stages of the same disease.

A genetic marker linked to a type of hair loss was found in most patients studied.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

HGF-modified hair follicle stem cells help brain recovery after injury in rats.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

The patient has frontal fibrosing alopecia (FFA).

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Avoiding salicylates improved skin issues and stabilized hair loss in a woman with frontal fibrosing alopecia.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.